Status: Available
Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)
The purpose of this expanded access protocol is to provide access to the investigational drug troriluzole in patients with spinocerebellar ataxia (SCA).
Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: Biohaven Pharmaceuticals, Inc.Updated: Jan 9, 2026
Eligibility criteria
Patient has a confirmed diagnosis of Spinocerebellar Ataxia (SCA), defined as ei... [+1]
Patient is known to have acute or chronic liver disease that is clinically signi... [+1]